NG2/Cspg4 Product List
Host Species
- Rabbit（1）
Conjugate
- Unconjugated（1）
Reactive Species
- Rabbit（1）
Applications
- ICC/IF（1）
| Molecule | Cat. No. | Product Name | Host Species | Reactive Species | Applications | Size&Price |
|---|---|---|---|---|---|---|
| NG2/Cspg4 | Polyclonal NG2/Cspg4 Antibody, Rabbit IgG |  Rabbit | Rabbit | $80.00 20ul |
You Have Viewed 1-1 Of 1 Results
Asset Licensing Opportunity
Resources
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Carotuximab | DE-122; TRC-105; Chimeric Antibody TRC-105; NSC#754227 | Phase 2 Clinical | Roswell Park Cancer Institute | Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Macular Degeneration; Carcinoma, Hepatocellular; Neoplasm Metastasis; Metastatic breast cancer; Adenoma, Liver Cell; Lung Neoplasms; Fallopian Tube Neoplasms; Glioma; Trophoblastic Tumor, Placental Site; Choriocarcinoma; Ureteral Neoplasms; Astrocytoma; Gliosarcoma; Peritoneal Neoplasms; Ovarian Neoplasms; Brain Neoplasms; Breast Neoplasms; Sarcoma; Oligodendroglioma; Prostatic Neoplasms, Castration-Resistant; Gestational Trophoblastic Disease; Liver Neoplasms, Experimental; Carcinoma, Transitional Cell; Neoplasms; Glioblastoma; Hemangiosarcoma; Trophoblastic Neoplasms; Carcinoma, Renal Cell; Liver Neoplasms; Solid tumours | Details |
| STEMVAC | EP-101 | Phase 2 Clinical | Epithany | Triple Negative Breast Neoplasms; Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| ENV-105 | ENV-105 | Phase 2 Clinical | Kairos Pharma Ltd | Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
Customer Reviews